Stay updated with breaking news from Philippe Picaut. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
IND opened and Fast Track Designation granted by FDA for Erythromelalgia First patients enrolled in ACT study in Chemotherapy-Induced Peripheral Neuropathy European biotech AlgoTx, a clinical
AlgoTx, a biotechnology company dedicated to developing treatments for complex pain, announced today the initiation of its Phase 2 global clinical trial in Chemotherapy-Induced Peripheral Neuropathy
European biotech AlgoTx, an innovator in complex pain therapy, today announces the U.S. Food and Drug Administration (FDA) cleared its Investigational New Drug Application (IND) for Phase 2 candidate